Fennec Pharmaceuticals Inc (FENC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 7,925 | 6,974 | 7,262 | 25,377 | 9,735 |
| Cost of Goods | 669 | 1,357 | 608 | 550 | 685 |
| Gross Profit | 7,256 | 5,617 | 6,654 | 24,827 | 9,050 |
| Operating Expenses | 8,859 | 11,176 | 12,301 | 11,634 | 11,553 |
| Operating Income | -934 | -5,202 | -5,039 | 13,743 | -1,818 |
| Interest Expense | 966 | 1,025 | 1,044 | 1,034 | 915 |
| Other Income | 280 | 492 | 530 | 128 | 51 |
| Pre-tax Income | -1,620 | -5,735 | -5,553 | 12,837 | -2,682 |
| Net Income Continuous | -1,985 | -5,735 | -5,553 | 12,837 | -2,682 |
| Net Income | $-1,985 | $-5,735 | $-5,553 | $12,837 | $-2,682 |
| EPS Basic Total Ops | -0.08 | -0.21 | -0.20 | 0.47 | -0.09 |
| EPS Basic Continuous Ops | -0.08 | -0.21 | -0.20 | 0.47 | -0.10 |
| EPS Diluted Total Ops | -0.02 | -0.21 | -0.20 | 0.41 | -0.09 |
| EPS Diluted Continuous Ops | -0.02 | -0.21 | -0.20 | 0.41 | -0.10 |
| EPS Diluted Before Non-Recurring Items | -0.06 | -0.21 | -0.20 | 0.41 | N/A |
| EBITDA(a) | $-813 | $-5,156 | $-4,990 | $14,486 | $-1,748 |